Cargando…

Gd(iii)–Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy

Pt(iv) prodrugs have emerged as versatile therapeutics for addressing issues regarding off-target toxicity and the chemoresistance of classic Pt(ii) drugs such as cisplatin and carboplatin. There is significant potential for Pt(iv) complexes to be used as theranostic agents, yet there are currently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, Casey J., Meade, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157322/ https://www.ncbi.nlm.nih.gov/pubmed/34084418 http://dx.doi.org/10.1039/c9sc05937g

Ejemplares similares

Polymerizable Gd(iii) building blocks for the synthesis of high relaxivity macromolecular MRI contrast agents
por: Berki, Thomas R., et al.
Publicado: (2021)

Redox double-switch cancer theranostics through Pt(iv) functionalised manganese dioxide nanostructures
por: Brito, Beatriz, et al.
Publicado: (2023)

An ultra-sensitive T(2)-weighted MR contrast agent based on Gd(3+) ion chelated Fe(3)O(4) nanoparticles
por: Chen, Jing, et al.
Publicado: (2020)

Polymeric Gd-DOTA amphiphiles form spherical and fibril-shaped nanoparticle MRI contrast agents
por: Randolph, Lyndsay M., et al.
Publicado: (2016)

Phase-shifted paclitaxel-loaded multifunctional contrast agent for US/MR imaging and synergistic hyperthermal/chemotherapy of metastasis in lymph nodes
por: Tang, Kui, et al.
Publicado: (2018)

Activatable molecular agents for cancer theranostics
por: Zhang, Jianjian, et al.
Publicado: (2019)

Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023)

Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents
por: Lu, Zheng-Rong, et al.
Publicado: (2006)

Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2015)

Design of A3B-Porphyrin Conjugates with Terpyridine as Potential Theranostic Agents: Synthesis, Complexation with Fe(III), Gd(III), and Photodynamic Activity
por: Zhdanova, Kseniya A., et al.
Publicado: (2023)

Synthesis, spectroscopic, thermal, antimicrobial and electrochemical characterization of some novel Ru(iii), Pt(iv) and Ir(iii) complexes of pipemidic acid
por: Alibrahim, Khuloud A., et al.
Publicado: (2018)

Magnetic interactions and in vitro study of biocompatible hydrocaffeic acid-stabilized Fe–Pt clusters as MRI contrast agents
por: Kostevšek, N., et al.
Publicado: (2018)

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
por: Petruzzella, Emanuele, et al.
Publicado: (2018)

AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer
por: Li, Jingjing, et al.
Publicado: (2019)

A theoretical study on the on–off phosphorescence of novel Pt(ii)/Pt(iv)–bisphenylpyridinylmethane complexes
por: Zhu, Guoxun, et al.
Publicado: (2022)

Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
por: Raveendran, Raji, et al.
Publicado: (2016)

Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications
por: Chang, Zhi-Xuan, et al.
Publicado: (2021)

Multimeric Near IR–MR Contrast Agent for Multimodal In Vivo Imaging
por: Harrison, Victoria S. R., et al.
Publicado: (2015)

Cell Labeling via Membrane-Anchored Lipophilic MR Contrast Agents
por: Carney, Christiane E., et al.
Publicado: (2014)

Short-wave near-infrared emissive GdPO(4):Nd(3+) theranostic probe for in vivo bioimaging beyond 1300 nm
por: Yang, Qiuhua, et al.
Publicado: (2018)

Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
por: Moynihan, Eoin, et al.
Publicado: (2021)

Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
por: Fu, Lei, et al.
Publicado: (2016)

The effects of three different contrast agents (Gd-BOPTA, Gd-DTPA, and Gd-DOTA) on brachial plexus magnetic resonance imaging
por: Zhang, Xiaojing, et al.
Publicado: (2021)

Revisiting the factors influencing the magnetic resonance contrast of Gd(2)O(3) nanoparticles
por: Liu, Yanyue, et al.
Publicado: (2021)

Active sites of atomically dispersed Pt supported on Gd-doped ceria with improved low temperature performance for CO oxidation
por: Li, Yuanyuan, et al.
Publicado: (2023)

Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt(IV) prodrug
por: Alonso-de Castro, Silvia, et al.
Publicado: (2017)

An intramolecular photoswitch can significantly promote photoactivation of Pt(iv) prodrugs
por: Deng, Zhiqin, et al.
Publicado: (2021)

Defining the conditions for the development of the emerging class of Fe(III)-based MRI contrast agents
por: Baranyai, Zsolt, et al.
Publicado: (2021)

MR Angiography of Collateral Arteries in a Hind Limb Ischemia Model: Comparison between Blood Pool Agent Gadomer and Small Contrast Agent Gd-DTPA
por: Jaspers, Karolien, et al.
Publicado: (2011)

A visible-light photoactivatable di-nuclear Pt(IV) triazolato azido complex
por: Yao, Kezi, et al.
Publicado: (2019)

Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T(1) contrast agent for high-field MRI
por: Song, YoungKyu, et al.
Publicado: (2015)

Optimizing the Relaxivity of MRI Probes at High Magnetic Field Strengths With Binuclear Gd(III) Complexes
por: Leone, Loredana, et al.
Publicado: (2018)

Gd-Si Oxide Nanoparticles as Contrast Agents in Magnetic Resonance Imaging
por: Cabrera-García, Alejandro, et al.
Publicado: (2016)

Gd(III)-DOTA-modified sonosensitive liposomes for ultrasound-triggered release and MR imaging
por: Jung, Suk Hyun, et al.
Publicado: (2012)

Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases
por: Granata, Vincenza, et al.
Publicado: (2019)

Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice
por: Grishenkov, Dmitry, et al.
Publicado: (2015)

Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications
por: Longo, Dario Livio, et al.
Publicado: (2017)

Multifunctionalized Microscale Ultrasound Contrast Agents for Precise Theranostics of Malignant Tumors
por: Fu, Jia-Wei, et al.
Publicado: (2019)

Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
por: Wu, Zijun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8eci8qbignoa61vcbg9e72ros